Carcinoid syndrome historical perspective: Difference between revisions
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
Please help WikiDoc by adding content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | Please help WikiDoc by adding content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | ||
{{Carcinoid syndrome}} | {{Carcinoid syndrome}} | ||
{{CMG}} | |||
==Overview== | |||
==Historical Perspective== | |||
Carcinoids were first characterized in 1907 by Siegfried Oberndorfer, a German [[pathologist]] at the University of Munich, who coined the term ''karzinoide'', or "carcinoma-like", to describe the unique feature of behaving like a [[benign tumour]] despite having a [[malignant]] appearance microscopically. The recognition of their endocrine-related properties were later described by Gosset and Masson in 1914, and these tumours are now known to arise from the enterochromaffin (EC) and enterochromaffin-like (ECL) cells of the gut. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 16:19, 25 September 2012
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
|
Carcinoid syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Carcinoid syndrome historical perspective On the Web |
|
American Roentgen Ray Society Images of Carcinoid syndrome historical perspective |
|
Risk calculators and risk factors for Carcinoid syndrome historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Carcinoids were first characterized in 1907 by Siegfried Oberndorfer, a German pathologist at the University of Munich, who coined the term karzinoide, or "carcinoma-like", to describe the unique feature of behaving like a benign tumour despite having a malignant appearance microscopically. The recognition of their endocrine-related properties were later described by Gosset and Masson in 1914, and these tumours are now known to arise from the enterochromaffin (EC) and enterochromaffin-like (ECL) cells of the gut.